Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

GU Debates 2019: Practice-changing developments in urothelial cancer (2/2)

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 09.04.19
Views: 1576

Dr Eleni Efstathiou chairs a discussion with Prof Thomas Steuber, Prof Peter Goebell and Prof Joaquim Bellmunt on the recent data presented at the 2019 GU Debates in Budapest, with a specific focus on patients with prostate and urothelial cancers.

In this video, the group acknowledge the sudden shift in bladder cancer research - which has resulted from genomic advances; including the use of The Cancer Genome Atlas Program (TCGA).

A more personalised treatment approach is anticipated in first-line metastatic urothelial carcinoma, along with checkpoint inhibition and targeted therapies; with potential applicability to the second-line setting.

The group also discuss novel data showing prolonged survival in the metastatic setting with immunotherapeutic agents; along with five phase III trials - in which the results are expected to be practice-changing.

They also conclude the discussion by highlighting the importance of patient communication in the clinic.

Watch part 1 of this video which covers the changing treatment paradigms for hormone-naïve and castration-resistant prostate cancer here.

This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).


Related videos

follow us

Tobacco Dependence e-learning

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation